Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for sedation in first rescue tracheal intubation in neurocritical care
ChiCTR2400081354Phase 4Not yet recruiting
- Sponsor
- Wuhan Fourth Hospital
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in Neurocritical illness, brain hemorrhage (ICH) and traumatic brain injury (TBI) (2 arms), sponsored by Wuhan Fourth Hospital. Primary endpoint: Success rate of first tracheal intubation. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Neurocritical illnessbrain hemorrhage (ICH)traumatic brain injury (TBI)
Beyond the preview
Go deeper on ChiCTR2400081354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081354.